Related Experiment Video
Updated: Jun 1, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Adaptive designs in clinical trials
1Managing Director, PharmaNet Clinical Services Pvt. Ltd., Mumbai, Maharashtra, India.
Perspectives in Clinical Research
|May 18, 2011
Summary
Adaptive trial designs offer a promising solution to the rising costs and long timelines in pharmaceutical development. These innovative approaches, particularly those utilizing Bayesian methods, can reduce patient numbers and trial duration, accelerating new drug availability.
Area of Science:
- Clinical Trials
- Pharmaceutical Development
- Biostatistics
Background:
- Drug development faces high costs, lengthy timelines, and increasing attrition rates, leading to stagnation.
- The US Food and Drug Administration's 2004 Critical Path Initiative highlighted the need for innovative clinical trial designs.
- Adaptive designs, incorporating interim analyses, have gained traction for pharmaceutical product development.
Purpose of the Study:
- To describe various adaptive trial designs used in clinical research.
- To explore stakeholder perspectives on the feasibility of implementing adaptive designs.
- To provide an overview without delving into complex mathematical details.
Main Methods:
- Review of adaptive trial designs and their historical context.
- Discussion of the role of interim analysis (IA) in adaptive trials.
- Exploration of Bayesian approaches and their increasing use in adaptive designs due to technological advancements.
Main Results:
- Adaptive designs show potential to reduce patient numbers, trial duration, and drug exposure.
- While interim analysis is not new, planned and compliant methods are key to adaptive designs.
- Advances in computing have enabled the practical application of complex Bayesian techniques in adaptive trials.
Conclusions:
- Adaptive designs represent a significant innovation in clinical trial methodology.
- The integration of Bayesian statistics and interim analysis enhances the efficiency of drug development.
- Further exploration of stakeholder views is crucial for the successful adoption of adaptive designs.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
01:16Crossover Experiments
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
01:20Study Designs in Epidemiology
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.